Journal Information
Vol. 42. Issue 4.
Pages 206 (April 2006)
Letters to the Editor
Full text access
Bronchiectasis and Macrolides
Visits
4095
M. Vila-Justriboa, J. Dorca-Sargatalb, S. Bello-Drondac
a Hospital Arnau de Vilanova, Lleida, Spain
b Hospital de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain
c Hospital Miguel Servet, Zaragoza, Spain
This item has received
Article information
Full text is only available in PDF
REFERENCES
[1]
L Máiz Carro.
Tratamiento con azitromicina a largo plazo en un paciente con bronquiectasias idiopáticas.
Arch Bronconeumol., 41 (2005), pp. 295-296
[2]
A Jaffe, A Bush.
Anti-inflammatory effects of macrolides in lung disease.
Pediatr Pulmonol., 31 (2001), pp. 464-473
[3]
N Oligaki.
Bacterial biofilm in chronic airway infection.
Kasenshogaku Zasshi., 68 (1994), pp. 138-151
[4]
GW Amsden.
Anti-inflammatory effects of macrolides—an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?.
J Antimicrob Chemother., 55 (2005), pp. 10-21
[5]
BK Rubin, MO Henke.
Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.
Chest, 125 (2004), pp. 70-78
[6]
P Scheinberg, E Shore, on behalf of the PC-TNDS-008 Study Group.
A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
Chest, 127 (2005), pp. 1420-1426
Copyright © 2006. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?